Founded by myeloma research pioneer and oncologist, James R. Berenson, M.D., OncoTracker provides proprietary serum BCMA testing, patient-derived xenografts (PDX), access to an ongoing extensive library of clinically characterized biospecimens, and consultative services, to help pharmaceutical and biotechnology companies develop and evaluate new drugs.  OncoTracker’s facilities, including a state-of-the-art GLP laboratory and biorepository, are ideally suited to support drug development and clinical studies worldwide. 

Located in West Hollywood, CA, the company has provided critical testing, biospecimens, patient-derived xenografts and consultative guidance to research institutions, pharmaceutical companies and contract research organizations around the world to further the development of BCMA-directed drugs.  OncoTracker welcomes the opportunity to discuss how its unique testing services and programs may help your drug development needs.

ONCOtracker, Inc

Org chart

Teams

Offices

ONCOtracker, Inc

Org chart

Teams

Offices

Related companies